Menu
Recruiting NCT06754475

Effects of Upper Extremity Low Volume HIIT in Heart Failure

No phase Interventional High Intensity Interval Training Heart Failure Exercises

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Low-volume, high-intensity interval training, Standart medical treatment.
Who it may be relevant to
Registry conditions: High Intensity Interval Training, Heart Failure, Exercises. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients

Overview

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.

Detailed description

Patients in the DV-HIIT group will receive training consisting of 4 minutes of warm-up and cool-down at 50% Wmax on an arm ergometer, 1 minute of training at 85-95% Wmax work intensity, followed by 6 interval training periods including 1 minute of active recovery periods at 50-70% Wmax, 2 days/week, totaling 8 weeks of training. The control group will be followed with standard medical treatment.

Interventions

  • Other Low-volume, high-intensity interval training
    Low-volume, high-intensity interval training with an arm ergometer will be given two days a week for a total of eight weeks.
  • Drug Standart medical treatment
    Standart medical teatment

Primary outcome measures

  • maximal arm exercises capacity [Time frame: At baseline and after 8 week]
  • Functional capacity [Time frame: At baseline and after 8 week]
  • Upper extremity muscle strength [Time frame: At baseline and after 8 week]
  • reaction time [Time frame: At baseline and after 8 week]
  • cognitive function [Time frame: At baseline and after 8 week]
  • Postural sway [Time frame: At baseline and after 8 week]
  • heart rate variablity [Time frame: At baseline and after 8 week]
Secondary outcome measures (3)
  • hand steadness [Time frame: At baseline and after 8 week]
  • Anxiety and depresion [Time frame: At baseline and after 8 week]
  • activities of daily living [Time frame: At baseline and after 8 week]

Eligibility criteria

Inclusion criteria

  • Clinical condition stable for ≥4 weeks.
  • New York Heart Association functional classification I-II to III
  • Over 18 years old

Exclusion criteria

History of CABG surgery

  • Unstable angina pectoris
  • Severe arrhythmia
  • Acute pericarditis, endocarditis, myocarditis
  • Severe left ventricular failure (EF <40%)
  • Acute pulmonary embolism
  • History of syncope
  • Dissecting aneurysm
  • Thrombophlebitis
  • Orthopedic disorders that may interfere with exercise
  • Uncontrolled hypertension, severe pulmonary arterial hypertension
  • Moderate-severe valve disease
  • Decompensated Congestive Heart Failure
  • Electrolyte abnormalities
  • Hypertrophic Cardiomyopathy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 2 centers
  • Tarsus University, TARSUS, Mersin — Mersin
  • Nurel Ertürk, TARSUS, Mersin — Yenişehir

Identifiers

NCT: NCT06754475 · 2024/17

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗